Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a randomized, balanced, open Label, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult, male and female human subjects.
Epistemonikos ID: 6dcb5536f4739f4a4529b52fb1b6596bafd4a2fd
First added on: May 11, 2024